Lista de obras -

A monoclonal antibody against mutated nucleophosmin 1 for the molecular diagnosis of acute myeloid leukemias

artículo científico publicado en 2010

Acute promyelocytic leukemia: recent advances in diagnosis and management

artículo científico publicado en 2008

An allele-specific rt-PCR assay to detect type A mutation of the nucleophosmin-1 gene in acute myeloid leukemia.

artículo científico publicado en 2008

Are blood donors an adequate control group to ascertain HCV prevalence in non-Hodgkin's lymphoma patients

artículo científico publicado en 2002

Atypical chronic myeloid leukemia with concomitant CSF3R T618I and SETBP1 mutations unresponsive to the JAK inhibitor ruxolitinib.

artículo científico publicado en 2014

CD20-selective inhibition of CD47-SIRPα “don't eat me” signaling with a bispecific antibody-derivative enhances the anticancer activity of daratumumab, alemtuzumab and obinutuzumab

artículo científico publicado en 2017

Cancer cell-expressed SLAMF7 is not required for CD47-mediated phagocytosis

artículo científico publicado en 2019

Characteristics and clinical correlates of MPL 515W>L/K mutation in essential thrombocythemia

artículo científico publicado en 2008

Cytogenetic and molecular diagnostic characterization combined to postconsolidation minimal residual disease assessment by flow cytometry improves risk stratification in adult acute myeloid leukemia

artículo científico publicado en 2010

Deoxycoformycin (pentostatin) in the treatment of splenic marginal zone lymphoma (SMZL) with or without villous lymphocytes

artículo científico publicado en 2005

Epstein-Barr virus-positive lymphoma after alemtuzumab therapy for B-cell chronic lymphocytic leukemia.

artículo científico publicado en 2009

Evaluation of the prognostic relevance of L-selectin and ICAM1 expression in myelodysplastic syndromes

scientific article published on 17 November 2007

Hepatitis B virus reactivation and alemtuzumab therapy

artículo científico publicado en 2005

Higher frequency of HCV in patients with non-Hodgkin lymphoma: is it enough to suggest an association with B-cell NHL?

artículo científico publicado en 2003

Identification of a potential "hotspot" DNA region in the RUNX1 gene targeted by mitoxantrone in therapy-related acute myeloid leukemia with t(16;21) translocation

artículo científico publicado en 2009

Identification of patients with poorer survival in primary myelofibrosis based on the burden of JAK2V617F mutated allele

artículo científico publicado en 2009

Long-lasting remission of primary hepatic lymphoma and hepatitis C virus infection achieved by the alpha-interferon treatment

artículo científico publicado en 2004

Molecular characterization of paediatric idiopathic hypereosinophilia

artículo científico publicado en 2010

Multidimensional radar dot-plots, do we need it for the screening of acute promyelocytic leukemia?

scientific article published on 25 April 2019

NPM1 gene deletions in myelodysplastic syndromes with 5q- and complex karyotype ⬇️

artículo científico publicado el 10 de marzo de 2011

Presenting features and treatment outcome of acute promyelocytic leukemia arising after multiple sclerosis ⬇️

artículo científico publicado el 29 de diciembre de 2010

Rapid detection of nucleophosmin (NPM1) mutations in acute myeloid leukemia by denaturing HPLC.

artículo científico publicado en 2005

Role of gamma-glutamyl cysteine synthetase (gamma-GCS) gene expression as marker of drug sensitivity in acute myeloid leukemias

artículo científico publicado en 2005

Splenic marginal zone lymphoma with or without villous lymphocytes. Hematologic findings and outcomes in a series of 57 patients

artículo científico publicado en 2004

Spontaneous apoptosis and proliferation detected by BCL-2 and CD71 proteins are important progression indicators within ZAP-70 negative chronic lymphocytic leukemia.

artículo científico publicado en 2010

Successful pregnancy after arsenic trioxide therapy for relapsed acute promyelocytic leukaemia

Temsirolimus, an mTOR inhibitor, in combination with lower-dose clofarabine as salvage therapy for older patients with acute myeloid leukaemia: results of a phase II GIMEMA study (AML-1107)

artículo científico publicado en 2011

The biology of acute promyelocytic leukemia and its impact on diagnosis and treatment

artículo científico publicado en 2006

The genotype nucleophosmin mutated and FLT3-ITD negative is characterized by high bax/bcl-2 ratio and favourable outcome in acute myeloid leukaemia.

artículo científico publicado en 2010

Toward optimization of postremission therapy for residual disease-positive patients with acute myeloid leukemia.

artículo científico publicado en 2008

Treatment of acute promyelocytic leukemia with gemtuzumab ozogamicin.

artículo científico publicado en 2006

Two cases of q-Fever in hairy cell leukemia

artículo científico publicado en 2014

Use of arsenic trioxide in secondary acute promyelocytic leukemia developing after treatment of multiple sclerosis with mitoxantrone.

artículo científico publicado en 2009

Lista de obras de

A monoclonal antibody against mutated nucleophosmin 1 for the molecular diagnosis of acute myeloid leukemias

Acute promyelocytic leukemia: recent advances in diagnosis and management

An allele-specific rt-PCR assay to detect type A mutation of the nucleophosmin-1 gene in acute myeloid leukemia.

Are blood donors an adequate control group to ascertain HCV prevalence in non-Hodgkin's lymphoma patients

Atypical chronic myeloid leukemia with concomitant CSF3R T618I and SETBP1 mutations unresponsive to the JAK inhibitor ruxolitinib.

CD20-selective inhibition of CD47-SIRPα “don't eat me” signaling with a bispecific antibody-derivative enhances the anticancer activity of daratumumab, alemtuzumab and obinutuzumab

Cancer cell-expressed SLAMF7 is not required for CD47-mediated phagocytosis

Characteristics and clinical correlates of MPL 515W>L/K mutation in essential thrombocythemia

Cytogenetic and molecular diagnostic characterization combined to postconsolidation minimal residual disease assessment by flow cytometry improves risk stratification in adult acute myeloid leukemia

Deoxycoformycin (pentostatin) in the treatment of splenic marginal zone lymphoma (SMZL) with or without villous lymphocytes

Epstein-Barr virus-positive lymphoma after alemtuzumab therapy for B-cell chronic lymphocytic leukemia.

Evaluation of the prognostic relevance of L-selectin and ICAM1 expression in myelodysplastic syndromes

Hepatitis B virus reactivation and alemtuzumab therapy

Higher frequency of HCV in patients with non-Hodgkin lymphoma: is it enough to suggest an association with B-cell NHL?

Identification of a potential "hotspot" DNA region in the RUNX1 gene targeted by mitoxantrone in therapy-related acute myeloid leukemia with t(16;21) translocation

Identification of patients with poorer survival in primary myelofibrosis based on the burden of JAK2V617F mutated allele

Long-lasting remission of primary hepatic lymphoma and hepatitis C virus infection achieved by the alpha-interferon treatment

Molecular characterization of paediatric idiopathic hypereosinophilia

Multidimensional radar dot-plots, do we need it for the screening of acute promyelocytic leukemia?

NPM1 gene deletions in myelodysplastic syndromes with 5q- and complex karyotype ⬇️

Presenting features and treatment outcome of acute promyelocytic leukemia arising after multiple sclerosis ⬇️

Rapid detection of nucleophosmin (NPM1) mutations in acute myeloid leukemia by denaturing HPLC.

Role of gamma-glutamyl cysteine synthetase (gamma-GCS) gene expression as marker of drug sensitivity in acute myeloid leukemias

Splenic marginal zone lymphoma with or without villous lymphocytes. Hematologic findings and outcomes in a series of 57 patients

Spontaneous apoptosis and proliferation detected by BCL-2 and CD71 proteins are important progression indicators within ZAP-70 negative chronic lymphocytic leukemia.

Successful pregnancy after arsenic trioxide therapy for relapsed acute promyelocytic leukaemia

Temsirolimus, an mTOR inhibitor, in combination with lower-dose clofarabine as salvage therapy for older patients with acute myeloid leukaemia: results of a phase II GIMEMA study (AML-1107)

The biology of acute promyelocytic leukemia and its impact on diagnosis and treatment

The genotype nucleophosmin mutated and FLT3-ITD negative is characterized by high bax/bcl-2 ratio and favourable outcome in acute myeloid leukaemia.

Toward optimization of postremission therapy for residual disease-positive patients with acute myeloid leukemia.

Treatment of acute promyelocytic leukemia with gemtuzumab ozogamicin.

Two cases of q-Fever in hairy cell leukemia

Use of arsenic trioxide in secondary acute promyelocytic leukemia developing after treatment of multiple sclerosis with mitoxantrone.